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and nondiabetics. Longitudinal mixed model analyses accounted for multiple catheteriza- 
tions and multiple grafts per patient. 
Results: Slightly fewer in situinternal thoraclc attely (ITA, n=2,394) and saphenous vein 
grafts (SVG, n=l0,018) were patent across time in diabetics than in nondiabetics 
(P=.OO6; Figure). Risk-adjusted patency declined progressively for both types of conduit 
(Pc.OOl), but the decline was more rapid for SVGs (Pc.001). 
Conclusion: Unlike percutaneous coronary interventions, coronary awry bypass graft 
patency is similar in diabetics and nondiabetics. Therefore, coronary artery bypass SUP 
gery should be as durable in diabetics as nondiabetics. 
(EF) was 22.7 %. The mean number of grafts was 2.5 per patient. Myoblast Cells were 
delivered successfully in all subjects without any injection-related complications. Purity of 
the cells ranged from 47% lo 98% CD56+ myoblasts. Nine months follow-up revealed no 
significant adverse events associated with either cell transplantation or the injection pro- 
cedure. One patient had non-sustained ventricular tachycardia. Echocardiography, PET 
and MRI scans showed evidence of viability in the area df grafted scar. The mean EF 
improved from 22.7% to 35.9%. 
Conclusion: These preliminary data suggest that autologous myoblast cell transplanta- 
tion. within an infarcted myocardium during CABG. was feasible and safe. Improvement 
in viability and wall thickness is encouraging. Future cllnical trials evaluating the effect of 
autologous myoblast cell transplantation on left ventricular function are warranled. Final 
results on 12 patients will be presented. 
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84BFO-6 Combined Angioplasty and Robotic Coronary Bypass 
Surgery in Multivessel Coronary Artery Disease 
Kenneth D. Stahl, Kenneth R. Fromkin, And@ Bochenek, Douglas W. Boyd, Thomas A. 
Vassiliades, Hratch L. Karamanoukian, Marek Cisowski, Cleveland Clinic Florida, 
Weston, FL 
Background: Long-term benefits of a left internal mammary artery graft (LIMA) to the left 
anterior descending coronary arlery (LAD) are well known. This can now be accom- 
plished with minimally invasive robotic surgery without stemotomy or cardiopulmonary 
bypass. A four institution trial of a hybrid revascularizatu- strategy involving minimally 
invasive surgery for LIMA graft to the LAD and percutaneous coronary intewantion (PCI) 
to non-LAD vessels is reporied for multivessel disease. 
Methods: 150 patients ware treated with robotic endoscoplc LIMA grafts to the LAD and 
PCI to non-LAD vessels. All surgery was carried out using the Aesop or Zeus intra-oper- 
ative robotic devices. No patient recewed a stern&my incision or was placed on car- 
diopulmonary bypass. PCI was performed on non-LAD vessels before or after surgery. 
Results: 317 vessels were treated in 150 patients (2.1 vessels/patient). There were no 
early or late mortalities. Based on “Intention to tread all patlents were deemed totally 
revascularlzed in this hybrid manner. Complications included two intra-operative myocar- 
dial infarctions during surgaly (1.5%) and 1 (0.73%) stroke during PCI. Follow-up was 
complete in 1361150 (90.1%) patients at a mean post-procedure time of 12.1 (0.5 - 35) 
months. Post-procedure angina class was 1 .I (1 - 2). 79 (52.3%) patients had follow-up 
angiogram at 13.1 (0.3 35) months, 100% of LIMA grafts were patent. 77/79 (97.5%) 
were Fitzgibbon ‘A’, 2i79 (2.5%) Fltzgibbon ‘8’. 12/79 (15.2%) PCI vessels showed 
angiographic restenosis and 3/79 (3.8%) were occluded. 10 (7.3%) patients underwent 
repeat PCI, none had repeat surgery. 
Conclusion: A hybrid revascularization strategy of atraumatic robotic LIMA grafting lo the 
LAD combined with PCI of non-LAD vessels can be carried out with minimal complica- 
tions. outstanding 1 year LAD patency rates, and excellent symptom relief in patients 
with multivessel coronary artery disease. This hybrid procedure combines the best of 
surgical and catheter based therapy in a minimally invasive manner. 
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848FO-4 Cardiac Outcome and Cost-Effectiveness One Year 
After Off-Pump and On-Pump Coronary Artery Bypass 
Surgery: Results From a Randomized Study 
Hendrik M. Nathoe. Diederik van Dljk. Erik W. Jansen, Willem J. Suyker, Jan C. 
Diephuis, Wim Jan van Boven, Aarl Brute! de la Riviera Cornelius Borst, Cor J. 
Kalkman, Diederick E. Grobbee, Erik Buskens, Peter P. de Jaegere, The OCTOPUS 
Study Group, University Medical Center Utrecht, Utrecht, The Netherlands. Isala Clinics, 
Zwolle. The Netherlands 
Background: Avoiding cardiopulmonary bypass during coronary artery bypass surgety 
may reduce perioperative morbidity and costs. It is, however, unknown whether cardiac 
outcome is similar to bypass surgery using cardiopulmonary bypass. The purpose of this 
study was to compare cardiac outcome and cost-effectiveness at one year between 
bypass surgery on the beating heart (off-pump surgery) and conventional bypass surgery 
with the use of cardiopulmonary bypass (on-pump surgery). 
Methods: In a multicenter randomized clinical trial, 142 patients were randomly assigned 
to off-pump surgery and 139 patients to on-pump surgely. Cardiac outcome, cost-effec- 
tiveness and grafl patency ware determined at one year after surgery. The uncertainty 
surrounding the cost-effectiveness analysis was addressed by standard bootstrap tech- 
niques. 
Results: At one year, survival free from stroke, myocardial infarction and coronary rs- 
intervention was 88.0% after off-pump and 90.6% after on-pump surgery (p=O.48). Sur- 
vival free from angina was 89.3% versus 89.0% (p=O.93), respectively. Grafl patency 
determined in a randomized subset of patients, was 91% in the off-pump and 93% in the 
on-pump group (p=O.65). Off-pump surgery reduced costs by $2329 (13.1%) per patient 
($15479 versus $17808; pcO.01). Quality adjusted lifetime after off-pump and on-pump 
surgery was 0.82 versus 0.83 year (p=O.70). The cost-effectiveness ratio for off-pump 
compared with on-pump surgery as estimated by bootstrapping, remained in 98% of esti- 
mates below the conservative ‘willingness to pay’ threshold of $20,000 per quality 
adjusted life year. 
Conclusions: At one year, off-pump surgery was more cost-effective than on-pump sw 
gery. while maintaining comparable cardiac outcome. In selected patients, off-pump sur- 
gary as an alternative for on-pump surgery is justified from an economic perspective. 
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1170-l 00 A Single Troponin I Concentration Measured 12 Hours 
After Onset of Chest Pain Accurately Reflects infarct 
84BFO-5 Safety and Feasibility of Autologous Myoblast 
Size as Measured by Gadolinium-DTPA Late 
Transplantation in Patients Undergoing Coronary 
Enhancement Magnetic Resonance Imaging 
Artery Bypass Grafting: Results From the United States Thomas N. Martin, Bjoern A. Groenning, Tracey Steedman, John E. Foster, Alex T. 
Experience Elliott, Henry J. Dargv?, Glasgow Cardiac Magnetic Resonance Unit, Glasgow, United 
Kinodom 
Nabil Dib Patnck McCarthy. Ann Campbell, Johnathan Dinsmore, Michael Yeager, W. R -1 
MacLellan. Grew Fonarow. Robert E. Michler. Diane Buchele. Marwan Ghazoul. 
Edward B..Diath&h, Arizona Heart Institute, Phoenix, AZ 
Background: Autologous myoblast cell transplantation to repair myocardial infarction 
has been shown to be safe and effective in preclinical studies. The objective of this study 
was to demonstrate the feasibility and safety of myoblast transplantation in humans. 
Methods: Patients scheduled to undergo elective coronary artery bypass grafting 
(CABG) ware enrolled in the US multicenter clinical trial over a one-year period. Subjects 
with previous myocardial infarction and a I& ventricular ejection fraction < 30% were eli- 
gible to participate. A skeletal muscle biopsy of approximately 2 to 5 grams was excised 
from each patient with subsequent isolation and expansion of myoblast cells over a 
period of 2-3 weeks. Between 3 and 30 direct injections of myoblasts were delivered into 
the area of infarction at the time of surgery using one of 4 escalating cell doses ranging 
from 10 million cells lo 300 million cells. Pre and post-injection ECG, echocardlogram, 
Halter monitoring, positron emission tomography (PET) and magnetic resonance imag- 
ing (MRI) were performed. 
Results: Eleven patients underwent autologous myoblast cell transplantation combined 
with CABG. The mean age of patients was 57 years. The mean baseline ejection fraction 
Background. The purpose of the study was to assess the relationship between the sin- 
gle measure of cardiac troponin I (Tnl) used in clinical practice (8 to 12 hours after onset 
of chest pain) and infarct size and left ventricular (LV) dimensions and systolic function 
as measured by magnetic resonance imaging (MR). 
Methods. 13 male and 6 female (mean (range) age=60 (37-83) years) incident hospital 
admisslons with acute coronary syndromes were consecutively recruited. 9119 (47%) 
were treated with primaly thrombolysis. Blood sampling for Tnl took place E-12 hours 
after onset of chest pain and samples for cratine kinase (CK) and CKMB were collected 
at admission, after 12 hours and at the MR scan. MR was performed at a median (range) 
of 69 (16-120) hours from onset of chest pain on a Siemens Sonata 1.5T system using a 
phased array chest coil. LV dimensions were evaluated by cinematographic (TrueFISP) 
breath-hold sequence. Late contrast enhanced (LE) MR was performed 15 minutes after 
peripheral injection of 0.2 mmollkg gadolinium-DTPA using a breath-hold segmented tur- 
boFLASH sequence with non-seledive inversion-recovery. Images were evaluated by 2 
independent and blinded observers. 
Results. Tnl (median (range) 24 (0.3-117) pg/ml) strongly correlated with LE volume 
(mean (SD) 13 (15) ml): r=O.El, p<O.OOOl and with LV ejection fraction (mean (SD) 59 
(9.7)%): r=-0.58. p=O.O009. Tnl was unrelated lo LV end-diaslollc (140 (36) ml) and end- 
ABSTRACTS - Myocardial Ischemia and Infarction 381A JACC March 19,2003 
systolic (58 (19) ml) volumes and LV mass (134 (42) g). CK (median (range)) at 8-12 
hours (620 (74-1344) IU/I) and at the MA scan (228 (57.2508) IUif) correlated with LE 
volume: wO.78, p=O.OOOl and w0.70, p=O.O02, respectively. CK (111 (69-4869) IUif) on 
admission was unrelated to LE volume. CKMB (median (range)) at 8-12 hours (54 (3.4. 
226) mg/ml) and at the MR scan (11 (1.2-406) mg/ml) correlated with LE volume: w0.59, 
p=O.Ol and r=0.58, ~~0.02, respectively. CKMB on admission was unrelated to LE vol. 
ume. 
Conclusions. Plasma concentrations of Tnl measured 8-12 hours after onset of chest 
pain are very closely related to the volume of late enhancement measured by MR sug- 
gesting that the currently recommended timing of Tnl sampling does provide an accurate 
reflection of infarct size. 
1170-101 Homorygote Mutation of Cl61 +T Polymorphism in the 
Exon 6 of Peroxisome Proliferator-Activated Receptor 
$3 Gene Is Associated With Onset of Premature 
Myocardial Infarction 
Tino-Hsrnq Chaq Yi-Heng LI, Jyh-Hong Chen, Hua-Lin Wu, Guey-Yueh Shi, National 
Cheng Kung University Medical Center, Tainan, TaiwanROC 
Background: Peroxisome prokferator-activated receptor (PPAR) is a nuclear receptor. 
Activation of PPAR y with ligands could modulate some gene transcription, thereby lead- 
ing to multiple antiatherogenic and fibrinolybc effects. However, the association between 
effect of Cl61 +T mutation of the exon 6 of PPARTJ and the onset of premature myocar- 
dial infarction IS not clarified. 
Methods: We recruited 146 patients (pts) (mean age 45 yr, 129 male) with premature 
myocardial infarction (Ml) (onset age 5 50 yr) and 146 control subjects (mean age 45.3 
yr, 120 male). Polymerase chain reaction and restrlction fragment length polymorphism 
were used to define ClGl-tT polymorphism. 
Results: The frequency of the PPAR j3 TT genotype among pts with premature Ml was 
significantly higher than that in control subjects (13% vs 5.5% odds ratio [OR] 2.6, 95% 
confidence interval [Cl] 1 .I to 6.1, p=O.O3). This association was not observed in CC, or 
CT genotypes. The homozygote TT genotype (OR 3.1, 95% Cl 1.2 to 7.9) smoking (OR 
3.5, 95% Cl 2.1 to 6.0) hypertension (OR 3.6, 95% Cl 1.9 to 6.9) and diabetes mellitus 
(OR 3.5, 95% Cl 1.5 to 8.4) were independent risk factors for premature Ml after adjust- 
ment of conventional risk factors. 
Conclusion: There was a significant association between the PPAR fl Cl61-1T 
homozygote mutation and the onset of premature Ml in our population. Effect of the TT 
genotype on the production and activity of PPAR ywarrants further investigation. 
1170-102 Reduced Post-Infarction Myocardial Apoptosis in 
Women: A Clue to Their Different Clinical Course? 
Giuseppe G. Biondi-Zoccar, Antonio Abbate, Rossana Bussani. Debora Camilot, Maria- 
Pia Di Manno, Alessandro Petrolini, Luigi M. Biasucci, Alfonso Baldi, Institute of 
Cardiology - Cathokc University of Rome, Rome, Italy 
Background. lschemic heart failure (HF) is less common and severe in women. Myocar- 
dial apoptosis has a fundamental role in post-infarctron remodeling, however, little is 
known about gender-modulation of post-infarction apoptosis. We investigated whether 
apoptosis late after acute myocardial Infarction (AMI) is drfferent in females in compari- 
son to males. 
Methods. Hearts from 21 men and 9 women dying 10 days-2 months after AMI were 
examrned at autopsy. Apoptotic rate (AR) at infarct site and apparently normal myocar- 
dium was assessed with in-situ end labeling for DNA fragmentation (TUNEL) and co- 
staining for caspase-3. We also performed co-stainings for PCNA and SC-35 to identify 
potential false positwe results at TUNEL. Results. AR in infarcted areas was B-fold 
higher in males than in females (21.2% vs 4.3%,p=O.O36). See Figure. This difference 
remained statistically significant even at multivariate analysis (p=O.O20) and was particu- 
larly evident in subjects with persistent infarct-related artery (IRA) occlusion. 
Conclusions. Myocardiocyte apoptosrs after AMI is more severe in men in comparrson 
to women. This difference may explain the more aggressive and progressive course of 
post-infarction HF in men and the relatively more benign LV remodeling in women. 
1170-103 Relation of Growth Hormone and Insulin-Like Growth 
Factor-l to Ventricular Remodeling in Acute Myocardial 
Infarction 
Maria I. Sosa Liprandi, Alvaro Sosa Liprandi, Victor D. Dar& Sergio Baratta. Miguel A. 
Gonzalez, Ricardo M. Iglesias, Carlos D. Pellegrinr, Ana Keselman, Eliseo Gonzalez, 
Sanatorio Mitre, Buenos Aires, Argentina 
Background Experimental data have suggested that early treatment with growth hor- 
mone (GH) and insulin-like growth factor-l(IGF-1) could attenuate ventricular remodeling 
after acute myocardial infarction. Our aim was to determine whether serum GH and IGF- 
1 level are related to ventricular remodeling in patients with acute myocardial infarction. 
Methods: Within 24 hours of chest pain onset, 52 consecutive patients were studied at 
baseline, on day 5, and at 6 weeks after the acute myocardial infarction. GH and IGF-1 
were measured and related to positive ventricular remodeling defined as an increase 
25% in left ventricular diastolic volume (LVDV), left ventricular systolic volume (LVSV). 
their variations (A EDV and A ESV) and ejection fraction (EF) evaluated by echocardio- 
graphy (Sympson’s method) on day 3 and 6 weeks. 
Results: Median value of GH was higher at baseline (2.19 ng/ml) and significantly 
decreased at day 5 (0.26 ng/ml) and 6 weeks (0.55 @ml) (p<O.oOl). IGF-1 significantly 
increased from baseline: mean 136i90 ng/ml, to day 5: mean164395 ng/ml and 6 weeks: 
mean ZOO&9 rig/ml, p< 0.0001). Patients with baseline IGF-1 below the median value 
showed less EF at 6 weeks than patients above the median: 46*11% versus 53r9.8% 
respectively (p=O.Ol), and significant increase ESV: AESV 9+18 versus AESV 2rl5 
(p=O.OZ). At day 5, IGF-1 below the median value was associated with a significant 
increase ESV: AESV 11.35+14 versus AESV 0.1 I+18 (p=O.O4). 
Patients with positive ventricular remodekng showed significant lower levels of IGF- 
1(117+84nglml) than those with negative remodeling (165*93ng/ml) (p=O.O5) at base- 
line, and day 5 (152+11 lng/ml versus 183*6lng/ml respectively) (p=O.O3). No significant 
differences were found at 6 weeks. No association was found between GH levels, ven- 
tricular remodeling and ejection fraction at baseline, day 5 and 6 weeks. 
Conclusions: There was a strong association of low serum levels of IGF-1 with left ven- 
tricular remodeling and impaired ventncular function at baseline and day 5. No relation 
was found with GH, a labtle and unstable biological marker. This results could suggest a 
protective role of IGF-1 to prevent the early remodeling process after myocardial infarc- 
tion. 
1170-104 ST Elevation Myocardial Infarction Caused by 
Spontaneous Distal Embolization From Unstable 
Lesions: Frequency and Sequelae of a Distinct 
Pathophysiological Entity 
Jose P. Henriques Felix Zijlstra, the Zwolle Myocardial Infarction Study Group, lsala 
Klinieken, Locatie Weezenlanden, Zwolle, The Netherlands 
Background: Distal embolization is an important feature in acute myocardial infarction. 
Previously, we demonstrated that distal embolization after primary angioplasty resulted 
in larger infarct size. However, distal embolization may in part be due to angroplasty. 
Therefore, we investigated the characteristics of patients with distal embolization before 
primary angioplasty. 
Methods: We assessed angiographic data of 631 patients. Distal embolization before 
angioplasty was defined as a distal filling defect with an abrupt ‘cut-of? in at least one of 
the peripheral coronary branches of the infarct related artery, distal to the infarct related 
segment. Follow-up was obtained at 30 days. 
Results: Distal embolization before angroplasty was visible in 30 (5%) patients. They 
were younger than patients without distal embolrzation (56~ vs. 6ly, p=O.O4). Patients 
with distal embolization before angroplasty had a higher rate of TIMI 2 or 3 flow before 
angioplasty (57% vs. 31%, p=O.O05), more often thrombus (53% vs.12%. pl (20% vs. 
7%, ~~0.03) and had a hrgher 30 day modality rate (10% vs. 2%. p=O.O3). 
Conclusions: Distal embolization before angioplasty can be visualized in 5% of the 
patients with acute myocardial infarction. It is associated with more thrombus, a lower 
angioplasty success rate and heralds a higher rate of intracoronary stenting. It is associ- 
ated with more Killip class>1 and higher 30 days mortality Patients with distal emboliza- 
tion before angioplasty are a distinct subset of patients with a high rate of complicated 
myocardial infarction. 
1170-105 Marked Reduction in No-Reflow With Late Initiation of 
Hypothermia in a Rabbit Myocardial Infarct Model 
Sharon L. Hale, Michael W. Dae, Robed A. Kloner. Good Samaritan Hospital, Los 
Angeles, CA, University of Southern California, Los Angeles, CA 
Background: Hypothermia rn conjunction with reperfusion (rep) is a novel approach for 
treatment of acute myocardlal infarction now being tried in humans. Whether reflow, an 
important predictor of clinical outcome, is changed when hypothermia is initiated late dur- 
ing ischemia is unknown. This study tests if myocardial hypothermia, starting near the 
end of ischemia and continuing for 2 hr of rep. protects microvasculature reducing no- 
reflow. Methods: Rabbit hearts recewed 30 min coronary artery occlusion/ 3 h rep. 
Regional hypothermia (H, n=lO) started 10 min before rep and continued for 2 hr of rep 
was compared with normothermia (N. n=lO). Regional myocardial blood flow (micro- 
spheres) was measured during occlusion and at the end of rep. The anatomic zone of 
no-reflow (thioflavin S in viva injection) and zone of macroscopic hemorrhage were mea- 
sured in the LV. Results: Myocardial temperature (” C) in H was decreased by 5.OkO.4 
from baseline (36.9-0.2) and remained about 32” during the cooling phase, returning to 
36.3+0.3 at 3 hr. N hearts remained within 0.2” of baseline (37.4+0.1) throughout. Both 
groups were equally ischemic during occlusion, but at the end of rep reflow to the prew- 
ously rschemic zone was significantly higher in H, 69+6% of normal blood flow vs 34*5% 
in N (p=.OOOl). The zone of anatomic no-reflow was significantly smaller in H, 12+4% of 
the ischemic zone vs 37*3% in N (p=.OOOl), and the macroscopic zone of hemorrhage 
